Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination

Detalles Bibliográficos
Autores principales: Inaba, Tohru, Okumura, Keita, Maekura, Chika, Muramatsu, Ayako, Kobayashi, Tsutomu, Kuroda, Junya, Nukui, Yoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004209/
https://www.ncbi.nlm.nih.gov/pubmed/35412265
http://dx.doi.org/10.1007/s12185-022-03349-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004209/
https://www.ncbi.nlm.nih.gov/pubmed/35412265
http://dx.doi.org/10.1007/s12185-022-03349-1

Ejemplares similares